Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02249143 · ClinicalTrials.gov registry record · NA

Duration of Continuous Positive Airway Pressure and Pulmonary Function Testing in Preterm Infants

A NA study, sponsored by Oregon Health and Science University.

Completed
Registry status
NA
Development phase
50
Enrollment target

NCT02249143: Completed NA study, sponsored by Oregon Health and Science University.

NCT02249143 is a NA study that has completed, run by Oregon Health and Science University. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02249143, a NA study, has completed, sponsored by Oregon Health and Science University.

COMPLETED
Registry status
NA
Development phase
50 participants
Enrollment target

Study Summary

The primary aim of this study is to quantify and compare changes in lung volumes (as measured by functional residual capacity) in premature infants stable on continuous positive airway pressure (CPAP), and then randomized to two additional weeks of CPAP and room air versus room air alone. We hypothesize that infants randomized to additional CPAP will demonstrate an increased functional residual capacity (at the end of the two week study period and prior to discharge) compared to those randomized to room air.

Primary Outcome

Functional residual capacity (FRC) was measured with the nitrogen washout technique. For the nitrogen washout technique, calibration is done with 2 known volumes, and a calibration line was constructed for the system at the specific flow rate and used to correlate the nitrogen washed out to the infant's FRC. The system corrected for dead space and corrected the FRC to body temperature, pressure, and water-saturated conditions. Acceptance criteria included: 1) infant supine and quietly asleep; 2)

Interventions

  • DEVICE CPAP and room air

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2014-09
Est. Completion 2017-09
Phase NA

What the finished NCT02249143 record still lists

NCT02249143 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 1 intervention - of which CPAP and room air is the first listed.

NCT02249143 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02249143 about?

NCT02249143 is a clinical study titled "Duration of Continuous Positive Airway Pressure and Pulmonary Function Testing in Preterm Infants". The primary aim of this study is to quantify and compare changes in lung volumes (as measured by functional residual capacity) in premature infants stable on continuous positive airway pressure (CPAP), and then randomized to two additional weeks of CPAP and room air versus room air alone. We hypothe...

What is the current status of trial NCT02249143?

This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2014-09. Estimated completion is 2017-09.

What interventions are being tested in trial NCT02249143?

The interventions under investigation include: CPAP and room air (DEVICE).

Who is sponsoring clinical trial NCT02249143?

This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02249143's enrollment target sits among peer trials

50 1279th of 2000 higher than 622 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02249143, the US trial registry maintained by the National Library of Medicine. NCT02249143 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.